Carcinoembryonic antigen levels as an indicator of the primary site in metastatic disease of unknown origin

Abstract

In 542 patients with metastatic disease arising from a known primary site, elevated CEA levels (greater than 10 ng/ml) were most often associated with metastatic disease originating from entodermally derived organs, breast, and mucinous ovarian primaries. This observation held true, in general, in a small series of 32 patients with metastatic disease arising from a primary site that had been unknown, but that was identified. Thus, although a CEA level below 10 ng/ml is of no use in pointing to a particular primary site, a value above 10 ng/ml suggests the site is more likely to be in an entodermally derived organ, breast or ovary containing a mucinous carcinoma. If liver metastases are present, there is an increased probability that the primary site will be found in the large bowel or pancreas.